Global Recombinant Human Follicle-stimulating Hormone Market Growth (Status and Outlook) 2022-2028

Code: RW00014866146
LP Information
Sep-2022
Life Sciences
102 Pages

The global market for Recombinant Human Follicle-stimulating Hormone is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Recombinant Human Follicle-stimulating Hormone market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Recombinant Human Follicle-stimulating Hormone market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Recombinant Human Follicle-stimulating Hormone market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Recombinant Human Follicle-stimulating Hormone market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Recombinant Human Follicle-stimulating Hormone players cover Merck, Ferring, Livzon, Gedeon Richter and GenSci, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Recombinant Human Follicle-stimulating Hormone market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Recombinant Human Follicle-stimulating Hormone market, with both quantitative and qualitative data, to help readers understand how the Recombinant Human Follicle-stimulating Hormone market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Recombinant Human Follicle-stimulating Hormone market and forecasts the market size by Type (75IU, 150IU and Others), by Application (Infertility Treatment and Assisted Reproductive Technology.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
75IU
150IU
Others
Segmentation by application
Infertility Treatment
Assisted Reproductive Technology
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Merck
Ferring
Livzon
Gedeon Richter
GenSci
Teva
ChangChun High & New Technology
ABL
Scripps Laboratories
Alphamab Oncology
Hunan Jingfeng Pharmaceutical
Qilu Pharmaceutical
Beijing SL Pharmaceutical
Chapter Introduction
Chapter 1: Scope of Recombinant Human Follicle-stimulating Hormone, Research Methodology, etc.
Chapter 2: Executive Summary, global Recombinant Human Follicle-stimulating Hormone market size and CAGR, Recombinant Human Follicle-stimulating Hormone market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Recombinant Human Follicle-stimulating Hormone revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Recombinant Human Follicle-stimulating Hormone revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Recombinant Human Follicle-stimulating Hormone market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Merck, Ferring, Livzon, Gedeon Richter, GenSci, Teva, ChangChun High & New Technology, ABL and Scripps Laboratories, etc.
Chapter 14: Research Findings and Conclusion

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Recombinant Human Follicle-stimulating Hormone Market Size 2017-2028
2.1.2 Recombinant Human Follicle-stimulating Hormone Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Recombinant Human Follicle-stimulating Hormone Segment by Type
2.2.1 75IU
2.2.2 150IU
2.2.3 Others
2.3 Recombinant Human Follicle-stimulating Hormone Market Size by Type
2.3.1 Recombinant Human Follicle-stimulating Hormone Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Type (2017-2022)
2.4 Recombinant Human Follicle-stimulating Hormone Segment by Application
2.4.1 Infertility Treatment
2.4.2 Assisted Reproductive Technology
2.5 Recombinant Human Follicle-stimulating Hormone Market Size by Application
2.5.1 Recombinant Human Follicle-stimulating Hormone Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Application (2017-2022)
3 Recombinant Human Follicle-stimulating Hormone Market Size by Player
3.1 Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Players
3.1.1 Global Recombinant Human Follicle-stimulating Hormone Revenue by Players (2020-2022)
3.1.2 Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Players (2020-2022)
3.2 Global Recombinant Human Follicle-stimulating Hormone Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Recombinant Human Follicle-stimulating Hormone by Regions
4.1 Recombinant Human Follicle-stimulating Hormone Market Size by Regions (2017-2022)
4.2 Americas Recombinant Human Follicle-stimulating Hormone Market Size Growth (2017-2022)
4.3 APAC Recombinant Human Follicle-stimulating Hormone Market Size Growth (2017-2022)
4.4 Europe Recombinant Human Follicle-stimulating Hormone Market Size Growth (2017-2022)
4.5 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size Growth (2017-2022)
5 Americas
5.1 Americas Recombinant Human Follicle-stimulating Hormone Market Size by Country (2017-2022)
5.2 Americas Recombinant Human Follicle-stimulating Hormone Market Size by Type (2017-2022)
5.3 Americas Recombinant Human Follicle-stimulating Hormone Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Human Follicle-stimulating Hormone Market Size by Region (2017-2022)
6.2 APAC Recombinant Human Follicle-stimulating Hormone Market Size by Type (2017-2022)
6.3 APAC Recombinant Human Follicle-stimulating Hormone Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Recombinant Human Follicle-stimulating Hormone by Country (2017-2022)
7.2 Europe Recombinant Human Follicle-stimulating Hormone Market Size by Type (2017-2022)
7.3 Europe Recombinant Human Follicle-stimulating Hormone Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Recombinant Human Follicle-stimulating Hormone by Region (2017-2022)
8.2 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size by Type (2017-2022)
8.3 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Recombinant Human Follicle-stimulating Hormone Market Forecast
10.1 Global Recombinant Human Follicle-stimulating Hormone Forecast by Regions (2023-2028)
10.1.1 Global Recombinant Human Follicle-stimulating Hormone Forecast by Regions (2023-2028)
10.1.2 Americas Recombinant Human Follicle-stimulating Hormone Forecast
10.1.3 APAC Recombinant Human Follicle-stimulating Hormone Forecast
10.1.4 Europe Recombinant Human Follicle-stimulating Hormone Forecast
10.1.5 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Forecast
10.2 Americas Recombinant Human Follicle-stimulating Hormone Forecast by Country (2023-2028)
10.2.1 United States Recombinant Human Follicle-stimulating Hormone Market Forecast
10.2.2 Canada Recombinant Human Follicle-stimulating Hormone Market Forecast
10.2.3 Mexico Recombinant Human Follicle-stimulating Hormone Market Forecast
10.2.4 Brazil Recombinant Human Follicle-stimulating Hormone Market Forecast
10.3 APAC Recombinant Human Follicle-stimulating Hormone Forecast by Region (2023-2028)
10.3.1 China Recombinant Human Follicle-stimulating Hormone Market Forecast
10.3.2 Japan Recombinant Human Follicle-stimulating Hormone Market Forecast
10.3.3 Korea Recombinant Human Follicle-stimulating Hormone Market Forecast
10.3.4 Southeast Asia Recombinant Human Follicle-stimulating Hormone Market Forecast
10.3.5 India Recombinant Human Follicle-stimulating Hormone Market Forecast
10.3.6 Australia Recombinant Human Follicle-stimulating Hormone Market Forecast
10.4 Europe Recombinant Human Follicle-stimulating Hormone Forecast by Country (2023-2028)
10.4.1 Germany Recombinant Human Follicle-stimulating Hormone Market Forecast
10.4.2 France Recombinant Human Follicle-stimulating Hormone Market Forecast
10.4.3 UK Recombinant Human Follicle-stimulating Hormone Market Forecast
10.4.4 Italy Recombinant Human Follicle-stimulating Hormone Market Forecast
10.4.5 Russia Recombinant Human Follicle-stimulating Hormone Market Forecast
10.5 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Forecast by Region (2023-2028)
10.5.1 Egypt Recombinant Human Follicle-stimulating Hormone Market Forecast
10.5.2 South Africa Recombinant Human Follicle-stimulating Hormone Market Forecast
10.5.3 Israel Recombinant Human Follicle-stimulating Hormone Market Forecast
10.5.4 Turkey Recombinant Human Follicle-stimulating Hormone Market Forecast
10.5.5 GCC Countries Recombinant Human Follicle-stimulating Hormone Market Forecast
10.6 Global Recombinant Human Follicle-stimulating Hormone Forecast by Type (2023-2028)
10.7 Global Recombinant Human Follicle-stimulating Hormone Forecast by Application (2023-2028)

11 Key Players Analysis
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Recombinant Human Follicle-stimulating Hormone Product Offered
11.1.3 Merck Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Merck Main Business Overview
11.1.5 Merck Latest Developments
11.2 Ferring
11.2.1 Ferring Company Information
11.2.2 Ferring Recombinant Human Follicle-stimulating Hormone Product Offered
11.2.3 Ferring Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Ferring Main Business Overview
11.2.5 Ferring Latest Developments
11.3 Livzon
11.3.1 Livzon Company Information
11.3.2 Livzon Recombinant Human Follicle-stimulating Hormone Product Offered
11.3.3 Livzon Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Livzon Main Business Overview
11.3.5 Livzon Latest Developments
11.4 Gedeon Richter
11.4.1 Gedeon Richter Company Information
11.4.2 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product Offered
11.4.3 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Gedeon Richter Main Business Overview
11.4.5 Gedeon Richter Latest Developments
11.5 GenSci
11.5.1 GenSci Company Information
11.5.2 GenSci Recombinant Human Follicle-stimulating Hormone Product Offered
11.5.3 GenSci Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 GenSci Main Business Overview
11.5.5 GenSci Latest Developments
11.6 Teva
11.6.1 Teva Company Information
11.6.2 Teva Recombinant Human Follicle-stimulating Hormone Product Offered
11.6.3 Teva Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Teva Main Business Overview
11.6.5 Teva Latest Developments
11.7 ChangChun High & New Technology
11.7.1 ChangChun High & New Technology Company Information
11.7.2 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Product Offered
11.7.3 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 ChangChun High & New Technology Main Business Overview
11.7.5 ChangChun High & New Technology Latest Developments
11.8 ABL
11.8.1 ABL Company Information
11.8.2 ABL Recombinant Human Follicle-stimulating Hormone Product Offered
11.8.3 ABL Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 ABL Main Business Overview
11.8.5 ABL Latest Developments
11.9 Scripps Laboratories
11.9.1 Scripps Laboratories Company Information
11.9.2 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product Offered
11.9.3 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Scripps Laboratories Main Business Overview
11.9.5 Scripps Laboratories Latest Developments
11.10 Alphamab Oncology
11.10.1 Alphamab Oncology Company Information
11.10.2 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product Offered
11.10.3 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Alphamab Oncology Main Business Overview
11.10.5 Alphamab Oncology Latest Developments
11.11 Hunan Jingfeng Pharmaceutical
11.11.1 Hunan Jingfeng Pharmaceutical Company Information
11.11.2 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Offered
11.11.3 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Hunan Jingfeng Pharmaceutical Main Business Overview
11.11.5 Hunan Jingfeng Pharmaceutical Latest Developments
11.12 Qilu Pharmaceutical
11.12.1 Qilu Pharmaceutical Company Information
11.12.2 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Offered
11.12.3 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Qilu Pharmaceutical Main Business Overview
11.12.5 Qilu Pharmaceutical Latest Developments
11.13 Beijing SL Pharmaceutical
11.13.1 Beijing SL Pharmaceutical Company Information
11.13.2 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Offered
11.13.3 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Beijing SL Pharmaceutical Main Business Overview
11.13.5 Beijing SL Pharmaceutical Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. Recombinant Human Follicle-stimulating Hormone Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of 75IU
Table 3. Major Players of 150IU
Table 4. Major Players of Others
Table 5. Recombinant Human Follicle-stimulating Hormone Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Recombinant Human Follicle-stimulating Hormone Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Type (2017-2022)
Table 8. Recombinant Human Follicle-stimulating Hormone Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Recombinant Human Follicle-stimulating Hormone Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Application (2017-2022)
Table 11. Global Recombinant Human Follicle-stimulating Hormone Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Player (2020-2022)
Table 13. Recombinant Human Follicle-stimulating Hormone Key Players Head office and Products Offered
Table 14. Recombinant Human Follicle-stimulating Hormone Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Recombinant Human Follicle-stimulating Hormone Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Regions (2017-2022)
Table 19. Americas Recombinant Human Follicle-stimulating Hormone Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Country (2017-2022)
Table 21. Americas Recombinant Human Follicle-stimulating Hormone Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Type (2017-2022)
Table 23. Americas Recombinant Human Follicle-stimulating Hormone Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Application (2017-2022)
Table 25. APAC Recombinant Human Follicle-stimulating Hormone Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Region (2017-2022)
Table 27. APAC Recombinant Human Follicle-stimulating Hormone Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Type (2017-2022)
Table 29. APAC Recombinant Human Follicle-stimulating Hormone Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Application (2017-2022)
Table 31. Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Country (2017-2022)
Table 33. Europe Recombinant Human Follicle-stimulating Hormone Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Type (2017-2022)
Table 35. Europe Recombinant Human Follicle-stimulating Hormone Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Recombinant Human Follicle-stimulating Hormone
Table 44. Key Market Challenges & Risks of Recombinant Human Follicle-stimulating Hormone
Table 45. Key Industry Trends of Recombinant Human Follicle-stimulating Hormone
Table 46. Global Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Recombinant Human Follicle-stimulating Hormone Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Recombinant Human Follicle-stimulating Hormone Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Recombinant Human Follicle-stimulating Hormone Market Size Market Share Forecast by Application (2023-2028)
Table 52. Merck Details, Company Type, Recombinant Human Follicle-stimulating Hormone Area Served and Its Competitors
Table 53. Merck Recombinant Human Follicle-stimulating Hormone Product Offered
Table 54. Merck Recombinant Human Follicle-stimulating Hormone Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Merck Main Business
Table 56. Merck Latest Developments
Table 57. Ferring Details, Company Type, Recombinant Human Follicle-stimulating Hormone Area Served and Its Competitors
Table 58. Ferring Recombinant Human Follicle-stimulating Hormone Product Offered
Table 59. Ferring Main Business
Table 60. Ferring Recombinant Human Follicle-stimulating Hormone Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Ferring Latest Developments
Table 62. Livzon Details, Company Type, Recombinant Human Follicle-stimulating Hormone Area Served and Its Competitors
Table 63. Livzon Recombinant Human Follicle-stimulating Hormone Product Offered
Table 64. Livzon Main Business
Table 65. Livzon Recombinant Human Follicle-stimulating Hormone Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Livzon Latest Developments
Table 67. Gedeon Richter Details, Company Type, Recombinant Human Follicle-stimulating Hormone Area Served and Its Competitors
Table 68. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product Offered
Table 69. Gedeon Richter Main Business
Table 70. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Gedeon Richter Latest Developments
Table 72. GenSci Details, Company Type, Recombinant Human Follicle-stimulating Hormone Area Served and Its Competitors
Table 73. GenSci Recombinant Human Follicle-stimulating Hormone Product Offered
Table 74. GenSci Main Business
Table 75. GenSci Recombinant Human Follicle-stimulating Hormone Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. GenSci Latest Developments
Table 77. Teva Details, Company Type, Recombinant Human Follicle-stimulating Hormone Area Served and Its Competitors
Table 78. Teva Recombinant Human Follicle-stimulating Hormone Product Offered
Table 79. Teva Main Business
Table 80. Teva Recombinant Human Follicle-stimulating Hormone Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Teva Latest Developments
Table 82. ChangChun High & New Technology Details, Company Type, Recombinant Human Follicle-stimulating Hormone Area Served and Its Competitors
Table 83. ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Product Offered
Table 84. ChangChun High & New Technology Main Business
Table 85. ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. ChangChun High & New Technology Latest Developments
Table 87. ABL Details, Company Type, Recombinant Human Follicle-stimulating Hormone Area Served and Its Competitors
Table 88. ABL Recombinant Human Follicle-stimulating Hormone Product Offered
Table 89. ABL Main Business
Table 90. ABL Recombinant Human Follicle-stimulating Hormone Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. ABL Latest Developments
Table 92. Scripps Laboratories Details, Company Type, Recombinant Human Follicle-stimulating Hormone Area Served and Its Competitors
Table 93. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product Offered
Table 94. Scripps Laboratories Main Business
Table 95. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Scripps Laboratories Latest Developments
Table 97. Alphamab Oncology Details, Company Type, Recombinant Human Follicle-stimulating Hormone Area Served and Its Competitors
Table 98. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product Offered
Table 99. Alphamab Oncology Main Business
Table 100. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Alphamab Oncology Latest Developments
Table 102. Hunan Jingfeng Pharmaceutical Details, Company Type, Recombinant Human Follicle-stimulating Hormone Area Served and Its Competitors
Table 103. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Offered
Table 104. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Hunan Jingfeng Pharmaceutical Main Business
Table 106. Hunan Jingfeng Pharmaceutical Latest Developments
Table 107. Qilu Pharmaceutical Details, Company Type, Recombinant Human Follicle-stimulating Hormone Area Served and Its Competitors
Table 108. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Offered
Table 109. Qilu Pharmaceutical Main Business
Table 110. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. Qilu Pharmaceutical Latest Developments
Table 112. Beijing SL Pharmaceutical Details, Company Type, Recombinant Human Follicle-stimulating Hormone Area Served and Its Competitors
Table 113. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Offered
Table 114. Beijing SL Pharmaceutical Main Business
Table 115. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. Beijing SL Pharmaceutical Latest Developments
List of Figures
List of Figures
Figure 1. Recombinant Human Follicle-stimulating Hormone Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Type in 2021
Figure 7. Recombinant Human Follicle-stimulating Hormone in Infertility Treatment
Figure 8. Global Recombinant Human Follicle-stimulating Hormone Market: Infertility Treatment (2017-2022) & ($ Millions)
Figure 9. Recombinant Human Follicle-stimulating Hormone in Assisted Reproductive Technology
Figure 10. Global Recombinant Human Follicle-stimulating Hormone Market: Assisted Reproductive Technology (2017-2022) & ($ Millions)
Figure 11. Global Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Application in 2021
Figure 12. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Player in 2021
Figure 13. Global Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Recombinant Human Follicle-stimulating Hormone Market Size 2017-2022 ($ Millions)
Figure 15. APAC Recombinant Human Follicle-stimulating Hormone Market Size 2017-2022 ($ Millions)
Figure 16. Europe Recombinant Human Follicle-stimulating Hormone Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size 2017-2022 ($ Millions)
Figure 18. Americas Recombinant Human Follicle-stimulating Hormone Value Market Share by Country in 2021
Figure 19. Americas Recombinant Human Follicle-stimulating Hormone Consumption Market Share by Type in 2021
Figure 20. Americas Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Application in 2021
Figure 21. United States Recombinant Human Follicle-stimulating Hormone Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Recombinant Human Follicle-stimulating Hormone Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Recombinant Human Follicle-stimulating Hormone Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Recombinant Human Follicle-stimulating Hormone Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Region in 2021
Figure 26. APAC Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Application in 2021
Figure 27. China Recombinant Human Follicle-stimulating Hormone Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Recombinant Human Follicle-stimulating Hormone Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Recombinant Human Follicle-stimulating Hormone Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Recombinant Human Follicle-stimulating Hormone Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Recombinant Human Follicle-stimulating Hormone Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Recombinant Human Follicle-stimulating Hormone Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Country in 2021
Figure 34. Europe Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Type in 2021
Figure 35. Europe Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Application in 2021
Figure 36. Germany Recombinant Human Follicle-stimulating Hormone Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Recombinant Human Follicle-stimulating Hormone Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Recombinant Human Follicle-stimulating Hormone Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Recombinant Human Follicle-stimulating Hormone Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Recombinant Human Follicle-stimulating Hormone Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Application in 2021
Figure 44. Egypt Recombinant Human Follicle-stimulating Hormone Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Recombinant Human Follicle-stimulating Hormone Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Recombinant Human Follicle-stimulating Hormone Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Recombinant Human Follicle-stimulating Hormone Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Recombinant Human Follicle-stimulating Hormone Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 50. APAC Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 51. Europe Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 53. United States Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 54. Canada Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 57. China Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 58. Japan Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 59. Korea Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 61. India Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 62. Australia Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 63. Germany Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 64. France Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 65. UK Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 66. Italy Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 67. Russia Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 68. Spain Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 71. Israel Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Recombinant Human Follicle-stimulating Hormone Market Size 2023-2028 ($ Millions)

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE